$249.88
1.01%
NYSE, Sep 12, 10:00 pm CET
ISIN
IE00BFY8C754
Symbol
STE

Steris Stock price

$249.88
+6.12 2.51% 1M
+25.43 11.33% 6M
+44.32 21.56% YTD
+3.40 1.38% 1Y
+37.88 17.87% 3Y
+82.71 49.48% 5Y
+185.81 290.01% 10Y
+225.62 929.84% 20Y
NYSE, Closing price Fri, Sep 12 2025
-2.55 1.01%

Key metrics

Basic
Market capitalization
$24.6b
Enterprise Value
$26.2b
Net debt
$1.6b
Cash
$279.7m
Shares outstanding
-
Valuation (TTM | estimate)
P/E
38.2 | 24.5
P/S
4.4 | 4.1
EV/Sales
4.7 | 4.4
EV/FCF
28.9
P/B
3.5
Dividends
DPS
$2.23
Yield 1Y | 5Y
0.9% | 0.9%
Growth 1Y | 5Y
9.9% | 9.0%
Payout 1Y | 3Y
36.0% | 55.1%
Increased
20 Years
Financials (TTM | estimate)
Revenue
$5.6b | $6.0b
EBITDA
- | $1.7b
EBIT
$1.8b | $1.4b
Net Income
$646.6m | -
Free Cash Flow
$908.7m
Growth (TTM | estimate)
Revenue
8.5% | 9.2%
EBITDA
- | 19.9%
EBIT
94.5% | 41.8%
Net Income
61.6% | -
Free Cash Flow
53.0%
Margin (TTM | estimate)
Gross
-
EBITDA
- | 29.1%
EBIT
31.8%
Net
11.6% | -
Free Cash Flow
16.3%
Financial Health
Equity Ratio
65.1%
Return on Equity
9.3%
ROCE
18.7%
ROIC
14.7%
Debt/Equity
0.3
More
EPS
$6.5
FCF per Share
-
Short interest
0.9%
Employees
18k
Rev per Employee
$300.0k
Show more

Is Steris a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,012 stocks worldwide.

Steris Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Steris forecast:

10x Buy
77%
3x Hold
23%

Analyst Opinions

13 Analysts have issued a Steris forecast:

Buy
77%
Hold
23%

Financial data from Steris

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
5,571 5,571
9% 9%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 1,344 1,344
12% 12%
24%
- Research and Development Expense 108 108
5% 5%
2%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 1,769 1,769
95% 95%
32%
Net Profit 647 647
62% 62%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Steris directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Steris Stock News

Positive
Seeking Alpha
29 days ago
STERIS remains a high-quality, defensive cash recycler with diversified growth, expanding margins, strong cash conversion, and disciplined capital deployment. Q1 FY'26 results showed broad-based 9% revenue growth, margin expansion across all segments, and raised full-year guidance, supporting my positive investment view. Valuation is fair with upside to $270–$300/share; the company excels at re...
Neutral
Seeking Alpha
about one month ago
STERIS plc (NYSE:STE ) Q1 2026 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Daniel A. Carestio - President, CEO & Director Julie Winter - Vice President of Investor Relations & Corporate Communications Michael J.
Neutral
The Motley Fool
about one month ago
Steris (STE) Q1 Revenue Rises 8%
More Steris News

Company Profile

STERIS Plc (Ireland) engages in the manufacture of medical and surgical equipment. The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.

Head office Ireland
CEO Daniel Carestio
Employees 18,000
Founded 2016
Website www.steris.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today